MTAP loss by immunohistochemistry predicts worse survival and poor response to pemetrexed chemotherapy in pleural mesothelioma Meeting Abstract
| Authors: | Saliba, M.; Arfe, A.; Baine, M.; Bodd, F.; Chang, J.; Ortiz, E.; Wilson, C.; Linkov, I.; Mayoral, M.; Offin, M.; Ladanyi, M.; Ginsberg, M.; Rekhtman, N.; Yang, S. R.; Travis, W.; Zauderer, M.; Sauter, J. |
| Abstract Title: | MTAP loss by immunohistochemistry predicts worse survival and poor response to pemetrexed chemotherapy in pleural mesothelioma |
| Meeting Title: | 114th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP) - See the Light |
| Journal Title: | Laboratory Investigation |
| Volume: | 105 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2025 Mar 22-27 |
| Meeting Location: | Boston, MA |
| ISSN: | 0023-6837 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2025-03-01 |
| Start Page: | 103970 |
| Language: | English |
| ACCESSION: | WOS:001512928200036 |
| DOI: | 10.1016/j.labinv.2024.103970 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1725 -- Source: Wos |
